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Highlights 
 
 Non-B subtypes increased their prevalence across Western and Central Europe 
 In Eastern European countries, except Russia, subtypes’ distribution remains stable 
 Most prevalent non-B subtypes are A, C, F and G and the recombinants CRF01, CRF02 
 Migration from high prevalent areas is the reason for introducing divergent strains 






Abstract (297 words)  17 
Human Immunodeficiency Virus type 1 (HIV-1) is characterised by vast genetic diversity. 18 
Globally circulating HIV-1 viruses are classified into distinct phylogenetic strains 19 
(subtypes, sub-subtypes) and several recombinant forms. Here we describe the 20 
characteristics and evolution of European HIV-1 epidemic over time through a review of 21 
published literature and updated queries of existing HIV-1 sequence databases. HIV-1 22 
in Western and Central Europe was introduced in the early-1980s in the form of subtype 23 
B, which is still the predominant clade. However, in Eastern Europe (Former Soviet Union 24 
(FSU) countries and Russia) the predominant strain, introduced into Ukraine in the mid-25 
1990s, is subtype A (AFSU) with transmission mostly occurring in people who inject drugs 26 
(PWID). In recent years, the epidemic is evolving towards a complex tapestry with an 27 
increase in the prevalence of non-B subtypes and recombinants in Western and Central 28 
Europe. Non-B epidemics are mainly associated with immigrants, heterosexuals and 29 
females but more recently, non-B clades have also spread amongst groups where non-B 30 
strains were previously absent - non-immigrant European populations and amongst men 31 
having sex with men (MSM). In some countries, non-B clades have spread amongst the 32 
native population, for example subtype G in Portugal and subtype A in Greece, Albania 33 
and Cyprus. Romania provides a unique case where sub-subtype F1 has predominated 34 
throughout the epidemic. In contrast, HIV-1 epidemic in FSU countries remains more 35 
homogeneous with AFSU clade predominating in all countries. The differences between the 36 
evolution of the Western epidemic and the Eastern epidemic may be attributable to 37 
differences in transmission risk behaviours, lifestyle and the patterns of human mobility. 38 
The study of HIV-1 epidemic diversity provides a useful tool by which we can 39 
understand the history of the pandemic in addition to allowing us to monitor the spread 40 
and growth of the epidemic over time. 41 
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1. Introduction 44 
 45 
The Human immunodeficiency virus type 1 (HIV-1) epidemic is the most devastating in 46 
human history and remains a global public health problem with an estimated 2.5 million 47 
people living with HIV in the WHO European area in 2014 ((ECDC), 2015; Tebit and Arts, 48 
2011; UNAIDS, 2013). Around half of these people are undiagnosed making identification of 49 
transmission networks important for targeted public health intervention programmes. 50 
The origins of HIV can be traced to multiple zoonotic infections with Simian 51 
Immunodeficiency Viruses (SIV) from African non-human primates with the first HIV 52 
transmissions identified as occurring in the Democratic Republic of Congo (DRC) in the early 53 
1920s (Faria et al., 2014). There two major types of HIV, HIV type 1 and HIV type 2 (HIV-54 
2), with HIV-2 differing genetically by more than 55% from HIV-1 and being far less 55 
widespread. HIV-1 is characterised by its high genetic variability caused by its high 56 
replication rate, recombination and error-prone replication due to lack of proof reading 57 
activity of the reverse transcriptase enzyme resulting in high substitution rate. (Peeters and 58 
Sharp, 2000; Seillier-Moiseiwitsch et al., 1994). It is classified into four distinct groups: M 59 
(major), O (outlier), N (non-M, non-O), and P that was more recently identified, each 60 
corresponding to independent cross-species transmissions of SIVs from chimpanzees of 61 
the Central subspecies (Pan troglodytes troglodytes) and in Western lowland gorillas 62 
(Gorilla gorilla gorilla) (D'Arc et al., 2015; Gao et al., 1999; Peeters et al., 1989; Plantier et 63 
al., 2009; Simon et al., 1998; Van Heuverswyn et al., 2006) (Figure 1). Groups N and P 64 
viruses are geographically restricted to Central-Western Africa, notably Cameroon (Ayouba et 65 
al., 2000; Peeters et al., 1997; Vallari et al., 2011).  66 
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Group M viruses are responsible for the HIV-1 global pandemic, spreading out from Central 67 
Africa and are further classified in multiple phylogenetically distinct subtypes (A-D, F-H, J 68 
and K), sub-subtypes (A1, A2, F1 and F2) and recombinant forms. Existing clades (subtypes, 69 
sub-subtypes and recombinants) can further recombine resulting in new mosaic forms (Figure 70 
2). Recombinants include an expanding list of 79 circulating recombinant forms (CRFs) 71 
and multiple unique recombinant forms (URFs) 72 
(www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html).  73 
The HIV-1 subtypes/sub-subtypes global distribution is highly heterogeneous and varies 74 
geographically (Hemelaar, 2012). In 2004, subtype C was the most prevalent subtype 75 
globally, accounting for up to 50% of all infections, followed by A and B, with 12% and 10% 76 
respectively. However, subtype A viruses predominate in Central and Eastern African 77 
countries (Kenya, Uganda, Tanzania, and Rwanda), as well as in Eastern European countries 78 
formerly constituting the Soviet Union (FSU countries). Subtype B is the main HIV-1 clade 79 
in Western and Central Europe2, North America (including USA, Canada, Mexico), as 80 
well as in several countries in Central and South America, Caribbean, Australia, 81 
Northern Africa, and in the Middle East (Buonaguro et al., 2007). 82 
Based on the earliest AIDS diagnoses and molecular phylogenetic analyses of early 83 
strains, the introduction of HIV-1 in Europe dates back the to early-1980s (Brunet et al., 84 
1984; Glauser and Francioli, 1984; Melbye et al., 1984; Robbins et al., 2003). At that time, 85 
most infections were due to subtype B viruses and mainly associated with sexual 86 
transmissions among men having sex with other men (MSM) or men having sex with women 87 
(MSW), transfusions (haemophiliacs), and People Who Inject Drugs (PWID) (Brunet et al., 88 
1984; Melbye et al., 1984). Over the last 15 years, the molecular epidemiology of different 89 
HIV-1 subtypes and CRFs, referred to hereafter as HIV-1 clades, in Europe has 90 
                                                          
2
 Classification of European countries intro regions was according to the ECDC/WHO criteria 
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significantly changed becoming more heterogeneous (Abecasis et al., 2013; Hemelaar, 91 
2011). The increasing complexity raises plausible questions about potential issues in 92 
diagnosis, clinical management and even in pathogenesis (Camacho, 2006; Chaix et al., 93 
2013; Easterbrook et al., 2010; Geretti et al., 2009; Hemelaar, 2013; Paraskevis et al., 2013b; 94 
Santoro and Perno, 2013; Scherrer et al., 2011; Siemieniuk et al., 2013; Touloumi et al., 95 
2013). Investigation of the European HIV-1 epidemic by means of molecular 96 
epidemiology provides valuable information to investigate and monitor the epidemic’s 97 
dynamics over time (Frost and Pillay, 2015; Kuhnert et al., 2014; Pybus and Rambaut, 2009; 98 
Stadler and Bonhoeffer, 2013; Stadler et al., 2012). Interestingly, knowledge of the global 99 
HIV-1 clades’ distribution along with population distribution within a given area can, 100 
by itself, provide insights into transmission dynamics.  101 
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2. HIV-1 epidemiology in Europe 102 
 103 
The cumulative number of diagnosed HIV-1 infections in the European continent (i.e 104 
European Union, European Economic Area (EU/EEA), Russia and FSU countries) 105 
reached 1,840,136 by the end of 2014 with 49% of these diagnosed in Russia, as reported 106 
by The European Surveillance System (TESSy), a joint ECDC/WHO database for 107 
HIV/AIDS surveillance ((ECDC), 2015). In 2014, there were 142,197 newly diagnosed 108 
HIV-1 infected individuals in EU/EEA and Russia comprising the highest number since 109 
reporting started in the 1980s ((ECDC), 2015; AIDS, 2015). Of these new infections, 77% 110 
were diagnosed in the East, 19.2% in the West and 3.5% in the Centre of the European 111 
continent (using the TESSy/WHO criteria for the geographical division). The incidence 112 
was found to be more than 7 times higher in the Eastern than in the Western European 113 
countries (43.2 vs 6.4 per 100, 000 people) and considerably lower in the Central ones (2.6 114 
per 100, 000) ((ECDC), 2015). Despite public health intervention strategies and extensive 115 
prevention programmes to eliminate new HIV-1 infections implemented in the last 10 years in 116 
Europe, the rate of new infection has remained rather stable from 6.7 in 2005 to 6.4 per 117 
100,000 in 2014 (both adjusted for reporting delay). Interestingly, about one third of newly 118 
acquired HIV-1 infections are among immigrants (including foreign born individuals), whilst 119 
two thirds are among natives. The predominant route of HIV-1 transmission is sex between 120 
men, with a considerable increase in the rate of new HIV-1 infections among MSM from 30% 121 
in 2005 to 42% in 2014 ((ECDC), 2015). In Eastern European countries HIV-1 transmission 122 
through heterosexual intercourse is considered the main reason for the increased rate of new 123 
infections, while transmission through PWID networks also remains high.  124 
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3. Overview of HIV-1 diversity in Europe 125 
 126 
The geographical distribution and prevalence of HIV-1 clades in the European continent are 127 
highly heterogeneous. Briefly, since their introduction subtype B clade has predominated in 128 
most Western and Central European countries (Western-type epidemic), whilst in Eastern 129 
Europe the epidemic has been dominated by subtype A (AFSU) (Eastern-type epidemic) 130 
(Abecasis et al., 2013; Hemelaar, 2011). Interestingly though, the molecular epidemiology of 131 
the epidemic in West and Central Europe has significantly changed over the last 15 years. 132 
Non-B and/or CRF clades have been introduced mainly through waves of migration 133 
from areas where are predominant and have been spread through population mobility 134 
between European countries. Subsequently their prevalence in the Central and Western 135 
European region have been increased, because of dispersal through European and 136 
mainly regionally restricted MSM, PWID and heterosexual transmission networks 137 
increasing the complexity of the epidemic (Abecasis et al., 2013; de Oliveira et al., 2010; 138 
Fabeni et al., 2015; Fox et al., 2010; Hemelaar, 2011; Hoenigl et al., 2016; Simonetti et al., 139 
2014; Tamalet et al., 2015). Subtype B clade still predominates in Western and Central 140 
European countries, but each country has a unique pattern shaped by different regional 141 
circumstances and high prevalent local transmission routes. 142 
Conversely, in Eastern Europe the AFSU clade has predominated since the mid-1990s, when 143 
Russia and other FSUs had a very low incidence of HIV-1. Transmissions usually occurred 144 
through sexual intercourse and there were a large number of circulating strains, including B 145 
clade (Bobkova, 2013). At this stage the absolute number of cases was small and cases were 146 
largely confined to MSM. An explosive spread of an HIV-1 subtype A with very low genetic 147 
diversity was noted first in Ukraine in 1994 (Novitsky et al., 1998) and thereafter in Russia 148 
and Belarus (Bobkova, 2013), Azerbaijan (Saad et al., 2006a), Georgia (Zarandia et al., 2006) 149 
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and Armenia (Laga et al., 2015) amongst PWID. This subtype has been variably termed 150 
subtype IDU-A or AFSU (subtype A associated with states from the former Soviet Union) and 151 
is largely confined to PWID (Bobkov et al., 1997; Bobkov et al., 2004; Bobkova, 2013). 152 
Phylogenetic investigation of HIV-1 strains from Kiev, Crimea, Donetsk, Poltava and Odessa 153 
revealed that subtypes A and B were simultaneous introduced into Ukraine (Bobkova, 2013), 154 
however AFSU strains spread successfully across the FSU territory evolving into one of the 155 
fastest growing epidemics in the world, (Bobkova, 2013). HIV-1 subtype B clade infections 156 
remained stable in the area circulating mostly among MSMs (Thomson et al., 2009).  157 
  158 
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4. Prevalence of HIV-1 subtypes in Europe  159 
 160 
To describe the evolution of the European epidemic over time, including the changes in the 161 
prevalence of different clades, we used data from the SPREAD cohort (Strategy to Control 162 
Spread of HIV Drug Resistance); part of the ESAR collaboration (European Society for 163 
Translational Antiviral Research) (Abecasis et al., 2013), and the published review on the 164 
global prevalence of different HIV-1 subtypes by  Hemelaar et al. (Hemelaar, 2011). The 165 
SPREAD/ESAR cohort enrols newly diagnosed patients from 20 European countries and 166 
Israel, while the Hemelaar et al review reported estimates in Europe between 2004-2007 167 
(Hemelaar, 2011). The SPREAD cohort database reveals B clade as predominant (70.2%) in 168 
newly HIV-1 diagnosed patients, after adjusting for oversampling in some countries, followed 169 
by C, CRF02_AG, G and A, with 5.0%, 4.9%, 4.8% and 3.6%, respectively. However, there 170 
are countries, such as Portugal, Cyprus, Sweden and Greece, where subtype B viruses are less 171 
prevalent in new infections (<50%), whilst in the Czech Republic, Germany, Spain, Slovenia 172 
and Poland the prevalence of B clade exceeds 80%. Non-B and CRF clades have mainly been 173 
associated with immigrants, heterosexual transmission and male gender. Conversely, there is 174 
evidence for regional dispersal among native population of subtype A in Greece and subtype 175 
G in Portugal (Carvalho et al., 2015; Esteves et al., 2003; Paraskevis et al., 2007). Notably 176 
and unlike any other European country, in Romania the F clade (sub-subtype F1) has 177 
predominated since the begging of the epidemic in the late-1980s with as little as 5% of 178 
characterised HIV-1 strains belonging to non-F1 subtypes (Apetrei et al., 1998; Stanojevic et 179 
al., 2012). However, by 2007 the prevalence of non-F1 strains in treatment naïve individuals 180 
showed an increase up to 23% and included clades C, B and A (Paraschiv et al., 2007). 181 
Aligned with the SPREAD cohort data, Hemelaar et al, reported the B clade accounted for 182 
85.2% of the total infections in Western and Central European countries between 2004-2007.  183 
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Among the non-B clades, CRF02_AG was the most prevalent (4.5%) followed by C and A 184 
(1.91% and 1.76%, respectively). Notably, 9.3% of the total infections were due to CRFs 185 
and/or URFs (Hemelaar, 2011).  186 
Using the Los Alamos HIV Sequences Database, we investigated the prevalence of different 187 
clades over the last ten years (www.hiv.lanl.gov) in order to obtain a more recent picture of 188 
the molecular epidemiology of HIV-1 in Europe. The query resulted in a total of 30,996 HIV-189 
1 sequences across Western, Central and Eastern European countries with sampling dates 190 
since 2005. Overall, the results for Western and Central Europe (N=26,758) were in 191 
concordance with estimates from the SPREAD/ESAR cohort and specifically B clade was 192 
found to be the predominant (69.4%), followed by C (7.0%), A (3.5%), CRF02_AG (3.2%), F 193 
(3.0%), G (2.9%), CRF06_cpx (2.8%) and CRF01_AE (1.7%). The countries with the highest 194 
prevalence for non-B clades were Romania (85.4%), Ireland (68.2%), Luxembourg (67.2%), 195 
Portugal (63.0%), Bulgaria (62.5%), Cyprus (61.1%), Finland (57.1%), Greece (54.0%), 196 
United Kingdom (50.4%) and Sweden (49.2%) (Figure 3). In Eastern Europe (N=4,238), 197 
there is a trend towards increasing prevalence of non-A clades. Specifically in the Russian 198 
Federation the predominant clade is A followed by B (6.5%), CRF63_02A1 (8.9%), 199 
CRF02_AG (4.0%) and C clade (1.4%). In the rest of the FSU countries having adequate 200 
sampling, we found that subtype A (AFSU) remains the most prevalent clade and there 201 
have been no spill over of non-A clades from Russia or other Western and/ or Central 202 
European countries to these countries until to date. The only exception was Estonia where 203 
CRF06_cpx remains the predominant clade (Zetterberg et al., 2004). 204 
According to the above reviewed data in Western and Central European countries, A clade 205 
was the most prevalent among the non-Bs in Slovenia, Czech Republic, Poland, Greece and 206 
Cyprus, C predominated in the United Kingdom and Denmark, and subtype G in Portugal. 207 
Multiple clades were found at high prevalence in Switzerland (A, C, CRF01_AE, 208 
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CRF02_AG), Italy (C, F, G and CRF02_AG), Sweden (C and CRF01_AE), France (A, G, 209 
CRF01_AE and CRF02_AG) and Spain (A, C, F, G and CRF02_AG) (Figure 3).  210 
The approaches described above have several limitations. Specifically the SPREAD/ESAR 211 
cohort enrolled only newly diagnosed individuals. Similarly, Hemelaar et al reviewed HIV-1 212 
strains sampled between 2004 and 2007. Furthermore, the most recent published data for 213 
some of the countries are relatively old. On the other hand, figures available on the Los 214 
Alamos HIV sequences database are more recent, but the data may not reflect actual 215 
population frequencies and should be regarded as a rough indication of the subtype 216 
distributions. Therefore, maps drawn using the latest approach should be interpreted 217 
cautiously keeping in mind these limitations.     218 
  219 
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5. Origin of non-predominant HIV-1 clades in European countries 220 
 221 
Western Europe 222 
HIV-1 subtype B has been responsible for what is often called the ‘Western epidemic’ in 223 
Europe and has remained the predominant clade despite the introduction of non-B 224 
clades from later migrating populations. However, the prevalence of non-B subtypes has 225 
been increasing linked to migration and later dispersal through transmission networks 226 
with patterns varying between individual countries within the region. 227 
In the United Kingdom, HIV-1 was first identified during the 1980s among MSM with all 228 
identified strains belonging to B clade (Brown et al., 1997; I., 1988; Wade et al., 1998). 229 
However, the pattern in heterosexual groups is changing with a steady increase in the 230 
number of non-B clades since the 1990s (Hughes et al., 2009) and has mainly been 231 
associated with sub-Saharan African and South American immigration (de Oliveira et 232 
al., 2010; Fox et al., 2010; Resistance, 2014). Molecular epidemiological analyses revealed 233 
that non-B sequences among heterosexuals in the UK were initially strictly linked with 234 
strains from sub-Saharan Africa (Hughes et al., 2009), while the C clade viruses have 235 
been associated with South America (de Oliveira et al., 2010; Resistance, 2014). 236 
Nevertheless, a recently published study reported that the prevalence of non-B clades 237 
among MSM increased by more than 3 times between 2002 and 2010, and, despite the 238 
increase in non-B in heterosexual transmission networks, MSM and PWID are still at 239 
high risk for non-B infections (Ragonnet-Cronin et al., 2016). In Ireland a similar pattern of 240 
increasing prevalence of non-B subtypes acquired through heterosexual exposure has been 241 
observed (De Gascun et al., 2012) and the only subtype identified in Iceland was B up until 242 
1993 when the introduction of non-B subtypes was linked to immigration (Del Amo et al., 243 
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2011; Löve et al., 2000). Although non-Bs were introduced into Belgium somewhat 244 
earlier, in the mid-1980s, initial prevalence was relative low but increased over time, 245 
from 0% in 1983 (as reported in a small two-clinical sites study)  to 57% in 2001.  246 
(Fransen et al., 1996; Snoeck et al., 2004). Additionally in Belgium and Luxembourg 55.8% 247 
of non-B infections have been detected in individuals originated from Africa, but 30.5% of 248 
non-B clades were also found among native population (Dauwe et al., 2015). In the 249 
Netherlands the vast majority of non-Bs were linked to sub-Saharan Africa, in addition 250 
to single cases from the Caribbean, South America, Thailand, Russia and Italy (Bezemer 251 
et al., 2004; Op de Coul et al., 1998). Immigrants from sub-Saharan Africa also introduced 252 
non-B clades in France increasing the prevalence of non-B clades from 4% in the 1980s 253 
to more than 20% in just a decade, mostly spreading in MSM transmission networks 254 
(Barin et al., 1997; Chaix et al., 2013; Tamalet et al., 2015). Notably in a recent study, Brand 255 
et al, found that non-B clade infections have spread among individuals of French origin and 256 
especially MSM (Brand et al., 2014). Similarly Chaix et al found that a considerable 257 
proportion of French heterosexuals (37%) with a primary infection were infected with non-B 258 
clades (Chaix et al., 2013). France is probably the only West European country where a 259 
much higher proportion than in other countries reaching up to 23% of French Africans 260 
citizens are infected with subtype B, suggesting that the regional sub-epidemics in native 261 
and immigrant populations are linked (Chaix et al., 2013; Tamalet et al., 2015).  262 
Non-B clades were introduced relatively early in Switzerland with 28.2% of all infections as 263 
non-B by the mid-1990s (Böni et al., 1999). These infections are mainly associated with 264 
people of African origin (95%), heterosexual transmission (44%) and being female (43%). 265 
Conversely, subtype B clade was predominant in European, American and Asian immigrants, 266 
with particularly high frequencies in homosexuals (mostly MSM) (97%) and PWID (94%) 267 
(Böni et al., 1999). In a study reported by von Wyl et al, subtype C and CRF02_AG were 268 
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associated with being of African origin, whilst subtype A was found at similar proportions in 269 
western Europeans and Africans. However, CRF01_AE was detected more frequently among 270 
Western Europeans than South East Asians. All these non-B clades were mostly associated 271 
with heterosexual transmissions (von Wyl et al., 2011).  272 
In Austria, African immigrants were identified in most cases with non-Bs suggesting Africa 273 
as the putative origin of non-B infections that subsequently spread within MSM networks 274 
(Falkensammer et al., 2007; Hoenigl et al., 2016). In Germany, non-B clades have been 275 
detected at a 20% prevalence and were linked with migration from Sub-Saharan Africa 276 
(subtype A and CRF02_AG), Eastern Europe (AFSU) and South Eastern Asia (CRF01_AE) 277 
(personal communication with EIDB curators) ((EIDB), 2016). 278 
In Finland between 1988-1994 non-B clades were mainly transmitted heterosexually through 279 
direct or indirect contact with African or Southeast Asian populations. (Liitsola, 2000). Later, 280 
in 1998, Finland experienced an HIV-1 outbreak among PWID involving infections with 281 
CRF01_AE, which was probably introduced from South Eastern Asia (Angelis et al., 2015; 282 
Liitsola et al., 2000). In Sweden CRF01_AE strains circulating amongst PWID were 283 
introduced from Finland (Skar et al., 2011). The rest of non-B strains including all major 284 
subtypes and many different recombinants were introduced from different African regions 285 
(subtype C, CRF02_AG), South Eastern Asia (CRF01_AE), but also from Eastern Europe 286 
(CRF06_cpx) (Neogi et al., 2014). For Denmark the origin of non-B subtypes has not been 287 
described in detail.  288 
During the 1990s, non-B clades were also detected in Portugal, again linked with immigrant 289 
populations mainly African. Interestingly, G clade was also reported with high prevalence 290 
among PWID (34.1%, 1997-2001) (Esteves et al., 2003), unlike any other neighbouring or not 291 
country in the European continent. Although polyphyletic analyses suggested multiple and 292 
old introductions of the B and G clades, as expected, additional non-B and non-G clades 293 
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have established local epidemics among native individuals, with the dates of the most 294 
recent common ancestor estimated to be in the early 2000s (Carvalho et al., 2015). As in 295 
Portugal, the introduction of non-B clades in neighbouring Spain, was also documented in the 296 
mid to late-1990s, mainly among immigrants (Soriano et al., 1997). Yebra et al in a study 297 
from the Spanish ART Naïve cohort suggested that non-B strains were introduced by 298 
immigrants and subsequently circulated among natives in Spain (Yebra et al., 2012). In a 299 
study from Madrid, non-B transmissions were associated with people of African origin and 300 
heterosexuals (González-Alba et al., 2011). Specifically, CRF02_AG and subtype A were 301 
more frequently found among Africans, BG recombinants infected mainly PWID and BF 302 
recombinants circulated only in South Americans and Spaniards (González-Alba et al., 2011). 303 
Of particular note is Galicia in Northwest Spain where PWID viruses, the G and 304 
CRF14_BG clades were found to have originated from Portugal (Thomson et al., 2001; 305 
Thomson and Najera, 2007). Furthermore, an outbreak of subtype F1 was detected in 306 
northwest Spain (mostly in Galicia) including sequences from other Western European 307 
countries that were found to have originated from Southern America (Delgado et al., 2015; 308 
Paraskevis et al., 2015a).  309 
In Italy, Baldanti et al, showed that African ethnicity, heterosexual transmission route of 310 
infection and having a recent diagnosis (2000-2006) were independently associated with 311 
non-B infections (Baldanti et al., 2008). The latter was also demonstrated by Lai et al, who 312 
studied the prevalence of HIV-1 subtypes in 3,670 individuals from 50 centres in Italy 313 
between 1980 and 2008 (Lai et al., 2010). Results were very similar to the study reported by 314 
Baldanti et al, showing that the prevalence of non-B clades increased from 2.6% in 1980-315 
1992 to 18.9% in 1993-2008, affecting mostly heterosexuals (77.2%) and people of African 316 
origin (94.8% of African people carried a non-B strain) (Lai et al., 2010). Nevertheless, 317 
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MSM transmission networks have been reported recently to drive the expansion of non-318 
B Italian regional sub-epidemics (Fabeni et al., 2015; Simonetti et al., 2014).  319 
In Greece, subtype A, the most prevalent among the non-Bs, was found to spread among the 320 
native population. It was introduced from sub-Saharan Africa, as the result of a single 321 
founder event in the late-1970s (MRSA 1977.9; 95% highest posterior density interval, 322 
1973.7-1981.9). The other non-A non-B clades transmissions mostly occurred amongst 323 
heterosexual or immigrant population (Paraskevis et al., 2007). The origin of clades 324 
associated with PWID differs to the sexually transmitted epidemics in Greece. The origin of 325 
the four different clades circulating among PWID during an outbreak in Athens (detected in 326 
early 2011), was Afghanistan/Iran (CRF35_AD), Romania (CRF14_BG) and Greece 327 
(subtypes A and B) (Niculescu et al., 2015; Paraskevis et al., 2013a; Paraskevis et al., 2015b).  328 
Whilst Israel is a West Asian country, data from here is included in the SPREAD/ESAR 329 
cohort, and many other European studies, so is relevant for inclusions in the description 330 
of the epidemiology of HIV-1 in Europe.  Here, non-B clades were introduced via two 331 
major routes; C clade viruses originated from Ethiopia and infected mainly heterosexuals and 332 
AFSU clade was introduced from FSU countries and circulated and expanded mostly among 333 
PWID transmission networks (Grossman et al., 2015). 334 
 335 
Central Europe 336 
The HIV-1 epidemic in Central European countries also has the Western epidemic 337 
pattern. Up until 1999, only B clade was detected in Polish HIV-1 infected individuals 338 
(Stańczak et al., 2010) and mainly occurred in MSM (42%) and PWID (35%). Non-B 339 
clades (namely A1, C, D and F1) were introduced later and detected more frequently 340 
among heterosexuals and females (Parczewski et al., 2012; Parczewski et al., 2010; 341 
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Parczewski et al., 2016). Similarly in the Czech Republic and Slovakia, non-B strains were 342 
found almost exclusively in heterosexuals (Chabadova et al., 2014; Linka et al., 2008; Reinis 343 
et al., 2001). Between 2008 and 2010 in Hungary, 96.6% of the patients were infected with 344 
subtype B and 3.3% with subtype A (Mezei et al., 2011), whereas subtype C was detected 345 
during the late 90s in an isolated case, where the virus was contracted in Africa (Mezei et al., 346 
2000).  347 
In the Balkan states (Bosnia & Herzegovina, Bulgaria, Croatia, Former Yugoslav Republic of 348 
Macedonia (Fyrom), Montenegro and Slovenia but excluding Albania, Romania and Greece), 349 
both the epidemiology and prevalence of the various HIV-1 clades are similar to Central 350 
Europe and subtype B predominates in MSM (Mezei et al., 2006; Siljic et al., 2013). Other 351 
subtypes, particularly recombinant subtypes, have been increasing their prevalence since the 352 
beginning of the 21st century. Non-B transmissions in Slovenia were also associated with 353 
heterosexuals in contrast to Bs, which circulated among MSM (Stanojevic et al., 2012). 354 
Notably the majority of non-B infected individuals (86%) were of Slovenian nationality 355 
(Lunar et al., 2013; Stanojevic et al., 2012). Interestingly, the introduction of non-B viruses in 356 
Croatia was often reported to have occurred via heterosexual contact with seamen 357 
rather than immigrants from highly prevalent areas as is commonly found elsewhere 358 
(Ramirez-Piedad et al., 2009).  359 
In Albania, data from the last decade showed that the local HIV-1 epidemic was 360 
characterised by a high prevalence of non-B infections (65,2%) (Ciccozzi et al., 2005). 361 
Specifically, A clade spread as a result of a founder effect from the A clade epidemic in 362 
neighbouring Greece (Paraskevis et al., 2007; Salemi et al., 2008a). In Bulgaria, there are 363 
several HIV-1 clades circulating and as it has been shown clades B and A1 were introduced 364 
by at least three or four independent sources in last 25 years (Salemi et al., 2008b). Although 365 
B clade still predominates, with higher prevalence among women and PWID, there are 366 
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several clades (A1, B, C, F1 and H) and CRFs (namely CRFs; 01_AE, 02_AG, 04_cpx, 367 
05_DF, 14_BG, and 36_cpx) circulating among MSM and PWID, increasing the HIV-1 368 
epidemic heterogeneity (Alexiev et al., 2015; Ivanov et al., 2013).  In Serbia non-B clades 369 
(i.e G, C, A, F, CRF01 and CRF02) has mainly been transmitted heterosexually (Siljic et al., 370 
2013; Stanojevic et al., 2002). In Montenegro there is a low prevalence of subtype A and C 371 
viruses. However, the origin of the infections have not yet been identified (Ciccozzi et al., 372 
2011).  373 
In Romania, the HIV-1 epidemic is unique as the globally-rare subtype F1 predominates and 374 
any non-F1 subtypes are referred to as divergent strains.  Here, significant numbers of mainly 375 
institutionalised children were infected in the late 1980s via transfusion of infected blood 376 
products or unsafe parenteral treatments (Apetrei et al., 1997). Estimates suggest that as many 377 
as 10,000 children were infected (Lucking et al., 2013). However, B clade has been found 378 
amongst MSM and heterosexuals at approximately similar rates and have in fact been found 379 
to have originated from Western Europe (Paraschiv et al., 2012). There are other non-F1 and 380 
non-B clades also circulating with C clade mainly being associated with heterosexuals 381 
infected abroad (Paraschiv et al., 2011). Since 2010, an increasing trend of HIV-1 infections 382 
amongst PWID has been observed, largely centred in Bucharest. Although F1 clade still 383 
predominates in the PWID epidemic, other clades, including CRF14_BG, have also been 384 
found (Niculescu et al., 2015). The outbreak of CRF4_BG strains among PWID was found to 385 
have originated from Spain, whilst the two subtype F1 sub-outbreaks originated from 386 
regionally prevalent Romanian strains (Paraskevis et al., 2015b).  387 
Turkey was included in our analysis as a close, and therefore relevant, neighbour to the 388 
European continent. Here, the prevalence of non-B clades was high and included many 389 
different subtypes and CRFs. Unfortunately, the origin of these transmissions and/or local 390 
epidemics remains unclear (Inan and Sayan, 2014; Stanojevic et al., 2002). 391 
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Eastern Europe 392 
In the Eastern European sub-continent AFSU clade is the predominant and has been 393 
spread through a large PWID-epidemic in the mid-1990s. In the pre-PWID epidemic era, 394 
an early study (mid-1980s) from Belarus, Russia and Lithuania described the presence of 395 
HIV-1 subtype B clade in homosexually infected individuals and subtype C in heterosexually 396 
infected individuals, while A, C, D and G clades were also detected in parentally infected 397 
individuals (Lukashov et al., 1995). In the mid-1990s Ukraine experienced the begging of a 398 
large epidemic in the PWID communities which subsequently spread into the Russian 399 
Federation, Belarus, Moldova, Lithuania, Latvia, Kazakhstan, Kyrgyzstan, 400 
Turkmenistan, Georgia, Azerbaijan and Armenia (Bobkov et al., 1998; Bobkova, 2013; 401 
Saad et al., 2006b). The geographic origin of the AFSU PWID-epidemic was in Odessa and the 402 
tMRCA was approximately in 1993 (Diez-Fuertes et al., 2015). Moreover, the origin of the 403 
AFSU PWID-epidemic strain has been recently identified in Democratic Republic of Congo 404 
(DRC), and the upper limit of the dispersal time for the ancestral strain in 1970 (Diez-Fuertes 405 
et al., 2015). Besides the AFSU that dominates in FSU countries, subtype B transmissions have 406 
been described at low prevalence and are mainly associated with MSM, probably associated 407 
with the Western European epidemic (Bobkova, 2013).  408 
The epidemiology of the HIV-1 epidemic in the Baltic states of Estonia, Latvia and 409 
Lithuania is similar to the neighbouring countries of Belarus and Russia, where PWID 410 
transmission networks contribute significantly to the spread of the epidemic (Avi et al., 2014; 411 
Lai et al., 2014). In 2000, the rapid spread of HIV-1 amongst PWID intensified; when an 412 
outbreak was noted amongst PWID in Estonia’s Eastern regions (Adojaan et al., 2005). This 413 
was a large outbreak resulted in a prevalence to around 1000 HIV-1 infected per million, 414 
consisting the highest in the European Union (Avi et al., 2014). It was recognized from the 415 
early start that this outbreak involved a recombinant HIV-1 subtype which differs from the 416 
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predominant A clade circulating in neighbouring countries, called CRF06_cpx (Adojaan et 417 
al., 2005). The Estonian CRF06_cpx strain was likely originated in Africa (Zetterberg et al., 418 
2004), and although it has been reported in other European countries, it is a minority variant 419 
in all studies performed outside Estonia. Conversely, subtype A dominates in Latvia and 420 
Lithuania, where the HIV-1 epidemic is otherwise very similar and driven by injecting drug 421 
use (Andrews et al., 2013; Popa et al., 2013). More recently CRF02_AG has been 422 
increasingly detected amongst PWID in Russia and is probably linked with the CRF02_AG 423 
epidemics in Central Asia (Bobkova, 2013). 424 
The origin of non-predominant HIV-1 clades in Europe can be described according to the 425 
following three patterns: i) Cross-continental transmissions: Overall in Western Europe 426 
non-B clades have mostly been associated with immigration and heterosexual intercourse. 427 
This pattern has been remained consistent since the earliest stage of the epidemic. Non-B 428 
transmissions were detected at different proportions amongst individuals with a non-African 429 
origin in Western Europe. South Eastern Asia and South America are also a source of non-430 
B clades in Western European countries, but to a lesser extent than Africa. ii) Cross-431 
border infections across Western Europe: Non-B infections circulating across Western 432 
European countries such as subtype G infections in Luxemburg and Spain which have 433 
originated in Portugal; CRF14_BG in Spain, which also originated in Portugal; 434 
CRF01_AE epidemic among PWID in Sweden, which is regarded as a spill over from 435 
Finland and the F1 clade circulating in North-West Spain and other European countries 436 
iii) Cross-border transmissions across European areas: In this group there are examples 437 
of non-B transmissions in Eastern Europe which originated from Western Europe, such 438 
as the CRF14_BG from the Iberian Peninsula (Portugal and/or Spain) and the AFSU 439 
from Eastern Europe transmissions in Central and Western Europe introduced. Cross-440 
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border spill overs have also been discovered between Central Asia and Eastern Europe 441 
(Russian Federation).  442 
  443 
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6. HIV-1 subtypes in immigrants 444 
 445 
Population movements including migration from the African and Asian continents have 446 
transformed European countries over the past two decades and have been linked to several 447 
infectious disease outbreaks, including local HIV-1 epidemics (Kentikelenis et al., 2015).  448 
In 2013, epidemiological reports showed 39.9% of new HIV-1 infections were in immigrants. 449 
A large proportion of new HIV-1 infections were among immigrants from sub-Saharan Africa 450 
(54.3%), Latin America (12.2%), Western Europe (9.5%), and Central Europe (6%) ((ECDC), 451 
2013). Sub-Saharan Africa was identified as the origin of 13.8% of all HIV-1 diagnoses in the 452 
EU/EEA, 35.0% of heterosexually acquired infections and 38.3% of mother-to-child 453 
transmissions (MTCT), as shown by studies from Spain and the United Kingdom (Monge-454 
Maillo et al., 2009)  455 
Based on data from numerous molecular epidemiological studies reviewed above, non-B 456 
transmissions in Western Europe have been associated with immigrants from sub-Saharan 457 
Africa and to a lesser extent from South East Asia, South America and Eastern Europe. 458 
Phylogenetic analyses revealed that different proportions of regional transmissions occur 459 
amongst immigrants, as for example in Switzerland, where this proportion ranged between 460 
16% and 28% for several non-B clades (von Wyl et al., 2011). Lai et al showed that 461 
individuals from the generalised epidemic were less likely to belong within local clusters than 462 
individuals from South America and Italy (Lai et al., 2014). Notably, subtype B transmissions 463 
were found at 23% and 3% of Africans and immigrants from sub-Saharan Africa living in 464 
France and Spain, respectively, suggesting that these transmissions could have possibly 465 
occurred in Europe (Chaix et al., 2013; Rivas et al., 2013).  466 
Based on the fact that immigrants have mostly been infected with non-B strains, a valid 467 
hypothesis is that they were infected, at least at some proportions, before migrating and 468 
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therefore they could provide the main source of divergent strains in Europe. This picture is 469 
consistent in Western Europe where non-Bs predominate among non-Europeans. Of course 470 
there are exceptions, such as Greece and Portugal, where non-B infections have been spread 471 
within local sexual networks (Thomson and Najera, 2007). Notably, in Central Europe non-B 472 
clades are mainly linked with heterosexual route of transmission and not with non-European 473 
origin. On the other hand, non-Bs have a distinct pattern of epidemic spread in Eastern 474 
European countries, for instance in FSU countries are associated with regional dispersal in 475 
PWID and in Russian federation with heterosexual transmissions within local immigrants’ 476 
sexual networks. 477 
It is clear that migrating populations have played an important role in shaping the 478 
genetic heterogeneity of the HIV-1 epidemic in Western Europe. This finding is 479 
consistent with socioeconomic factors indicating higher migratory rates towards 480 
Western European countries rather than FSU countries and Russia.  481 
  482 
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7. Conclusions 483 
 484 
To conclude, the complexity of the European HIV-1 epidemic has been increasing in Western 485 
and Central Europe during recent years. The higher proportions of non-B clades and their 486 
increasing prevalence across Western and Central Europe reflect this. Conversely, in FSU 487 
countries, expect Russia, the epidemic is less complex where subtype A (AFSU) still 488 
predominates across different areas. Our review of numerous recently published studies and 489 
updated database queries suggest that the distribution of different clades greatly differs across 490 
Western and Central Europe, where the most prevalent non-B clades are A, C, F and G and 491 
the CRFs 01_AE and 02_AG.  The introduction of divergent strains occurs mostly through 492 
mobility from sub-Saharan Africa and circulation of these strains is more frequent 493 
amongst immigrants, local transmission networks, such as heterosexual, MSM and 494 
PWID (Abecasis et al., 2013). Although the origin of HIV-1 transmissions in immigrants 495 
warrants further investigation, preliminary analyses of the already published studies 496 
suggests that most of those coming from Africa, mainly sub-Saharan Africa, are infected 497 
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Figure Legends 506 
 507 
Figure 1: Phylogenetic tree of full-length genomic sequences from SIV infecting different 508 
monkey species (A) and HIV-1/SIVcpz (B) shown in different colours. ΗIV-1 and HIV-2 509 
groups are shown in red and stars indicate cross-species transmission events. Full-length 510 
sequence alignments were downloaded from the HIV Los Alamos sequence database.  511 
Phylogenetic tree of full-length genomic sequences from SIV infecting 512 
 513 
Figure 2: HIV-1 and HIV-2 classification scheme. In addition to groups, clades and 514 
recombinants described in this figure, there have been named several monophyletic 515 
clades of viruses circulating in specific geographic regions (e.g. the AFSU clade including 516 
sequences within subtype A circulating in Russia and other Former Soviet Union (FSU) 517 
countries). 518 
 519 
Figure 3: Map of the most prevalent non-B subtypes and recombinants across Europe as 520 
explained in the colour legend. The prevalence of subtype B for each country is drawn on 521 
grey scale. Information about the prevalence of HIV-1 clades was based on a query from 522 
the Los Alamos HIV sequence database for sequences sampled later than 2005 using a 523 
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